118000 Stock Chart & Stats
₩1267.00
-₩17.00(-1.32%)
―
--
Day’s Range― - ―
52-Week Range₩1,001.00 - ₩4,090.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)22.05K
Market Cap
₩28.32B
Enterprise Value₩96.59K
Total Cash (Recent Filing)₩11.07B
Total Debt (Recent Filing)₩73.97B
Price to Earnings (P/E)―
Beta0.12
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-120.76
Shares Outstanding22,055,784
10 Day Avg. Volume28,131
30 Day Avg. Volume22,055
Financial Highlights & Ratios
PEG Ratio-1.08
Price to Book (P/B)0.44
Price to Sales (P/S)1.60
P/FCF Ratio-2.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
118000 FAQ
What was Metacare Co., Ltd.’s price range in the past 12 months?
Metacare Co., Ltd. lowest stock price was ₩1001.00 and its highest was ₩4090.00 in the past 12 months.
What is Metacare Co., Ltd.’s market cap?
Metacare Co., Ltd.’s market cap is ₩28.32B.
When is Metacare Co., Ltd.’s upcoming earnings report date?
Metacare Co., Ltd.’s upcoming earnings report date is Nov 12, 2026 which is in 56 days.
How were Metacare Co., Ltd.’s earnings last quarter?
Metacare Co., Ltd. released its earnings results on Aug 13, 2026. The company reported ₩23.151 earnings per share for the quarter.
Is Metacare Co., Ltd. overvalued?
According to Wall Street analysts Metacare Co., Ltd.’s price is currently Undervalued.
Does Metacare Co., Ltd. pay dividends?
Metacare Co., Ltd. does not currently pay dividends.
What is Metacare Co., Ltd.’s EPS estimate?
Metacare Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Metacare Co., Ltd. have?
Metacare Co., Ltd. has 22,055,784 shares outstanding.
What happened to Metacare Co., Ltd.’s price movement after its last earnings report?
Metacare Co., Ltd. reported an EPS of ₩23.151 in its last earnings report. Following the earnings report the stock price went down -2.727%.
Which hedge fund is a major shareholder of Metacare Co., Ltd.?
Currently, no hedge funds are holding shares in KR:118000
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Metacare Co., Ltd.
Headquartered in Seoul, South Korea, Wooridul Huebrain Limited was founded in 2009. The company's operations span the medical, life and health, pharmaceutical, and storage industries. Its offerings include a range of medical equipment and devices, health-related apparatus, pharmaceutical products, and computer server solutions. The firm rebranded as Wooridul Huebrain Limited in April 2014, having previously operated under the name Wooridul Life Sciences Limited.
Technical Analysis
Daihan Scientific Co., Ltd
―
SANIGEN Co., Ltd.
―
Cellid Co., Ltd.
―
Precision Biosensor, Inc.
―
NGeneBio Co., Ltd.
―